Ann: Q&A on the merger of QBL MCL and Medcan, page-341

If they were just planning on growing for other companies then yield and price would be crucial but for a company wanting to produce and sell a medicine it doesnt really matter as much as how good their manafacture methods are in order to isolate the different compounds required for their product ie canntab. But even then, none of that really matters either until they put their product though clinical trials and can convince people to choose their medicine over the others that will be available by then.. time will tell i guess